Chinese Pharma Company Launches Generics Of Lilly's Zyprexa
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Hansenpharm Co. began selling generic versions of Lilly's blockbuster antipsychotic Zyprexa (olanzapine) in China this month after winning a groundbreaking lawsuit against Lilly late last year
You may also be interested in...
Lilly Zyprexa Patent Upheld On All Counts
The district court ruling means that generic versions of olanzapine are unlikely to enter the market before 2011, when the only "Orange Book" listed patent for Zyprexa is set to expire.
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).